Evommune Competitors and Similar CompaniesClear all

Gilead Sciences's competitors and similar companies include CanSino Biologics and Athenex.

	Gilead Sciences Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of medicines.	CanSino Biologics CanSino Biologics (康希诺生物股份公司) is a biopharmaceutical company that provides solutions for the prevention and treatment of infectious diseases.	Athenex Athenex is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of cancer.
Founding Date	Founding Date 1987	Founding Date 2009	Founding Date 2003
Type	Type Public	Type Public	Type Public
Tags	Tags Manufacturing & Industrial biotech clinical research drug development pharma	Tags Healthcare biotech clinical research drug development	Tags Healthcare Manufacturing & Industrial biotech clinical research drug development oncology pharma
Locations	Locations Foster City, US HQ Buenos Aires, AR Melbourne, AU Wien, AT Machelen, BE São Paulo, BR Edmonton, CA see more	Locations Tianjin, CN HQ	Locations Buffalo, US HQ Guatemala, GT Alderley Edge, GB see more
Employees	Employees 18,0006% increase	Employees 1,10526% decrease	Employees 575
Valuation ($)	Valuation ($) 110.5 b	Valuation ($) N/A	Valuation ($) 2.3 m
Financial
Revenue (est.)	Revenue (est.) $29.4b (FY, 2025)	Revenue (est.) ¥1.1b (FY, 2025)	Revenue (est.) $102.8m (FY, 2022)
Cost of goods	Cost of goods $6.2b (FY, 2025)	Cost of goods ¥81.4m (FY, 2025)	Cost of goods $76.1m (FY, 2022)
Gross profit	Gross profit $23.2b (FY, 2025)	Gross profit ¥1.1b (FY, 2025)	Gross profit $26.7m (FY, 2022)
Net income	Net income $8.5b (FY, 2025)	Net income ¥27.9m (FY, 2025)	Net income ($104.4m) (FY, 2022)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 76m	Total funding raised $ 252.1m